.FDA declines psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Approve MDMA Therapy, Looking For More Research Study The New York City TimesFDA Turns Down Ecstasy-Based Medication The Stock market JournalFDA declines to accept unique MDMA therapy to treat post-traumatic stress disorder, with ask for additional trial data CNNFDA declines to begin with experimental to address PTSD, asking for additional study The Washington Article.